Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets
about
Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-MetRON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cellsIsothiocyanatostilbenes as novel c-Met inhibitors.Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.Ovarian cancer stem cells: still an elusive entity?Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.The c-Met receptor: Implication for targeted therapies in colorectal cancer.Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.Impact of semaphorin expression on prognostic characteristics in breast cancer.
P2860
Q28828215-CA953F4A-649E-412A-ACD1-7492FB7E2D95Q33721142-491222FA-5463-4580-84A4-45B57799652EQ36562316-9B29E81D-BAAE-402D-8AD6-D30F1831C47FQ37564619-2C4F6CEB-F2F1-4118-8BC1-C911353DCC10Q37713683-B7578D7F-EDE3-44BA-A772-1A7EFBE55D96Q38617369-5DC17338-5988-4964-94DA-CCAFD5EDD2FCQ38793227-9468C97D-BD69-4C1B-A636-D1F22F5A4072Q38874084-5BAA03C4-D590-4632-A847-8EBD128C31DDQ38922319-D44AC441-421C-4E32-BD4C-0B57923160BAQ39274990-B7EA00CB-608A-4EA5-9587-B1C3C519C800Q39389369-4C3EA44F-7A3C-4088-A554-417DE31FE8DBQ51303205-B8C67258-ECE2-4983-8082-928354B2A960Q53591553-8D7D5DED-7E91-4FEC-B9D4-D2A11A32237AQ55333468-8CC059DD-A150-4F08-8918-F562AD084D1D
P2860
Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@ast
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@en
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@nl
type
label
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@ast
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@en
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@nl
prefLabel
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@ast
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@en
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Roles of c-Met and RON kinases ...... tential as therapeutic targets
@en
P2093
Anand Karnad
James W. Freeman
Katherine Chang
Shujie Zhao
P2860
P304
P3181
P356
10.18632/ONCOTARGET.3420
P407
P577
2015-02-28T00:00:00Z